{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T05:09:14Z","timestamp":1692767354879},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,8,21]],"date-time":"2009-08-21T00:00:00Z","timestamp":1250812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1007\/s11060-009-9985-2","type":"journal-article","created":{"date-parts":[[2009,8,20]],"date-time":"2009-08-20T14:02:59Z","timestamp":1250776979000},"page":"53-57","source":"Crossref","is-referenced-by-count":2,"title":["Rapid and sustained response of an intra- and extracranial large cell lymphoma mass to liposomal intrathecal Ara-C and R-MegaCEOP systemic chemotherapy"],"prefix":"10.1007","volume":"97","author":[{"given":"Lorenzo","family":"Falchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gunnellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Ferrazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Ascani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Marina","family":"Liberati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,21]]},"reference":[{"key":"9985_CR1","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1200\/JCO.2007.11.0700","volume":"25","author":"J Salzburg","year":"2007","unstructured":"Salzburg J, Burkhardt B, Zimmermann M et al (2007) Prevalence, clinical pattern and outcome of CNS involvement in childhood and adolescent non-Hodgkin\u2019s lymphoma differ by non-Hodgkin\u2019s lymphoma subtype. A Berlin-Frankfurt-Munster Group Report. J Clin Oncol 25:3915\u20133922","journal-title":"J Clin Oncol"},{"key":"9985_CR2","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1182\/blood.V91.4.1178","volume":"91","author":"K Besien Van","year":"1998","unstructured":"Van Besien K, Ha CS, Murphy S et al (1998) Risk factors, treatment and outcome of central nervous system recurrence in adults with intermediate grade and immunoblastic lymphoma. Blood 91:1178\u20131184","journal-title":"Blood"},{"key":"9985_CR3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1023\/A:1008394827806","volume":"11","author":"C Haioun","year":"2000","unstructured":"Haioun C, Besson C, Lepage E et al (2000) Incidence and risk factors of central nervous system relapse in histologically aggressive non-Hodgkin\u2019s lymphoma uniformly treated and receiving intrathecal central nervous system prophylaxis: a GELA study on 974 patients. Ann Oncol 11:685\u2013690","journal-title":"Ann Oncol"},{"key":"9985_CR4","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0959-8049(00)00171-4","volume":"36","author":"A Hollender","year":"2000","unstructured":"Hollender A, Kvaloy S, Lote K et al (2000) Prognostic factors in 140 adult patients with non-Hodgkin\u2019s lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis. Eur J Cancer 36:1762\u20131768","journal-title":"Eur J Cancer"},{"key":"9985_CR5","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3109\/02841869609084002","volume":"35","author":"N Keldsen","year":"1998","unstructured":"Keldsen N, Michalski W, Bentzen SM et al (1998) Risk factors for central nervous system involvement in non-Hodgkin-lymphoma: a multivariate analysis. Acta Oncol 35:703\u2013708","journal-title":"Acta Oncol"},{"key":"9985_CR6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1365-2141.2005.05703.x","volume":"131","author":"A McMillan","year":"2005","unstructured":"McMillan A (2005) Central nervous system-directed preventative therapy in adults with lymphoma. Br J Haematol 131:13\u201321","journal-title":"Br J Haematol"},{"key":"9985_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00277-005-1096-3","volume":"85","author":"K Jahnke","year":"2006","unstructured":"Jahnke K, Thiel E, Martus P et al (2006) Retrospective study of prognostic factors in non-Hodgkin lymphoma secondarily involving the central nervous system. Ann Hematol 85:45\u201350","journal-title":"Ann Hematol"},{"key":"9985_CR8","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1093\/annonc\/mdf175","volume":"13","author":"A Hollender","year":"2002","unstructured":"Hollender A, Kvaloy S, Nome O et al (2002) Central nervous system involvement following diagnosis of non-Hodgkin\u2019s lymphoma: a risk model. Ann Oncol 13:1099\u20131107","journal-title":"Ann Oncol"},{"key":"9985_CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/annonc\/mdl327","volume":"18","author":"V Boehme","year":"2007","unstructured":"Boehme V, Zeynalova S, Kloess M et al (2007) Incidence and risk factors of central nervous system recurrence in aggressive lymphoma\u2014a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin\u2019s Lymphoma Study Group (DSHNHL). Ann Oncol 18:149\u2013157","journal-title":"Ann Oncol"},{"key":"9985_CR10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.bbmt.2004.09.009","volume":"11","author":"YL Kasamon","year":"2005","unstructured":"Kasamon YL, Jones RJ, Piantadosi S et al (2005) High dose therapy and blood or marrow transplantation for non-Hodgkin lymphoma with central nervous system involvement. Biol Blood Marrow Transplant 11:93\u2013100","journal-title":"Biol Blood Marrow Transplant"},{"key":"9985_CR11","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1200\/JCO.2005.04.8819","volume":"24","author":"T Batchelor","year":"2006","unstructured":"Batchelor T, Loeffler JS (2006) Primary CNS lymphoma. J Clin Oncol 24:1281\u20131288","journal-title":"J Clin Oncol"},{"key":"9985_CR12","first-page":"2627","volume":"30","author":"FL Graham","year":"1970","unstructured":"Graham FL, Whitmore GF (1970) The effect of 1-beta-d-arabinofuranosyl-cytosine on growth, viability, and DNA synthesis of mouse L-cells. Cancer Res 30:2627\u20132635","journal-title":"Cancer Res"},{"key":"9985_CR13","first-page":"351","volume":"26","author":"H Pels","year":"2003","unstructured":"Pels H, Schulz H, Schlegel U et al (2003) Treatment of CNS lymphoma with the anti-CD20 antibody rituximab: experience with two cases and review of the literature. Onkologie 26:351\u2013354","journal-title":"Onkologie"},{"key":"9985_CR14","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1182\/blood-2002-06-1636","volume":"101","author":"JL Rubenstein","year":"2003","unstructured":"Rubenstein JL, Combs D, Rosenberg J et al (2003) Rituximab therapy for CNS lymphomas: targeting the leptomeningeal compartment. Blood 101:466\u2013468","journal-title":"Blood"},{"key":"9985_CR15","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mpo.2950180210","volume":"18","author":"AN Bekassy","year":"1990","unstructured":"Bekassy AN, Liliemark J, Garwicz S et al (1990) Pharmacokinetics of cytosine arabinoside in cerebrospinal fluid and of its metabolite in leukemic cells. Med Pediatr Oncol 18:136\u2013142","journal-title":"Med Pediatr Oncol"},{"key":"9985_CR16","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s11060-007-9353-z","volume":"84","author":"B Gleissner","year":"2007","unstructured":"Gleissner B, Chamberlain M (2007) Treatment of CNS dissemination in systemic lymphoma. J Neurooncol 84:107\u2013117","journal-title":"J Neurooncol"},{"key":"9985_CR17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00277-008-0645-y","volume":"88","author":"Y-L Kwong","year":"2009","unstructured":"Kwong Y-L, Yeung DYM, Chan JCW (2009) Intrathecal chemotherapy for hematologic malignancies: drugs and toxicities. Ann Hematol 88:193\u2013201","journal-title":"Ann Hematol"},{"key":"9985_CR18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1517\/14656566.9.2.301","volume":"9","author":"M Benesch","year":"2008","unstructured":"Benesch M, Urban C (2008) Liposomal cytarabine for leukemic and lymphomatous meningitis: recent developments. Expert Opin Pharmacother 9:301\u2013309","journal-title":"Expert Opin Pharmacother"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-009-9985-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11060-009-9985-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-009-9985-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T15:50:38Z","timestamp":1590076238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11060-009-9985-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,21]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["9985"],"URL":"https:\/\/doi.org\/10.1007\/s11060-009-9985-2","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,21]]}}}